Gland Pharma has informed that the Earnings Call for Investors/Analysts will be held on Wednesday, February 14, 2024 at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and nine months ended December 31, 2023. The details of the Earnings Call for Investors/Analysts are enclosed.
The above information is a part of company’s filings submitted to BSE.